Score of 91/100 qualifies for PaymentCheck Certification
MEDIK8 LIMITED demonstrates a strong central payment tendency, with an average payment time of 12 days and 92% of invoices settled within 30 days, indicating a generally prompt payment culture. However, the 5% of payments exceeding 60 days represents a notable tail risk that pulls against the otherwise positive short-term payment profile. The concentration of payments at the faster end of the spectrum suggests a consistent operational preference for early settlement, though the 60-day outliers warrant monitoring.
The 28% late payment rate is a significant reliability concern and stands in sharp contrast to the 12-day average, suggesting that while the majority of payments are processed quickly, a material minority of invoices experience meaningful delays. The gap between the 92% within-30-days figure and the 28% late rate indicates that a substantial portion of invoices have agreed payment terms shorter than 30 days, making the lateness metric more pronounced than the bucket data alone implies. This inconsistency introduces moderate unpredictability, particularly for suppliers managing tight cash flow cycles.
MEDIK8 LIMITED presents a mixed but broadly acceptable risk profile, suitable for most standard supplier engagements given the strong 12-day average and high within-30-day compliance. Suppliers should, however, apply clear contractual payment terms and proactively monitor the 28% late payment rate, particularly for high-value invoices where delayed settlement could create cash flow pressure. To mitigate exposure, consider incorporating early payment incentives or escalation clauses for invoices approaching the 60-day threshold.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2025 - 31 Dec 2025 | 28 May 2026 | 12 | 91% | 4% | 5% | 24% |
| 01 Oct 2024 - 31 Mar 2025 | 28 May 2026 | 12 | 92% | 3% | 5% | 28% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The company does not have standard payment terms. These are negotiated individually on supplier by supplier basis. The most frequently used payment terms are 30 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
75
Any supplier dispute relating to invoices, pricing, quantities, service delivery, payment status, or purchase order discrepancies must be formally raised with the Finance team as soon as identified. Finance will coordinate the review process and work jointly with the business team that originally raised the purchase order to investigate and resolve the matter in a timely and collaborative manner. Suppliers may be requested to provide supporting documentation where necessary, and no disputed payment will be processed until the issue has been satisfactorily resolved and approved by the relevant stakeholders.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Medik8 Limited is a British skincare brand that develops and sells dermatological skincare products, including serums, moisturisers, cleansers and sunscreens, aimed at addressing concerns such as fine lines, dryness, blemishes, hyperpigmentation and redness. Its Companies House classification covers the manufacture of soap and detergents, consistent with producing finished skincare formulations sold directly to consumers via its own online store and through professional and clinic channels. The company markets its offering as clinically proven skincare and operates a customer rewards scheme alongside its product ranges. It is registered in Hertfordshire and remains an active company.
Generated from the company's website and Companies House records. Sources: medik8.com · medik8.com